Karin Collett

2.5k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

Karin Collett is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Karin Collett has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Karin Collett's work include Breast Cancer Treatment Studies (12 papers), Pregnancy and preeclampsia studies (7 papers) and Cancer Cells and Metastasis (5 papers). Karin Collett is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Pregnancy and preeclampsia studies (7 papers) and Cancer Cells and Metastasis (5 papers). Karin Collett collaborates with scholars based in Norway, United States and Canada. Karin Collett's co-authors include Lars A. Akslen, Ingunn M. Stefansson, Ole J. Halvorsen, Svein A. Haukaas, Oddbjørn Straume, Arie P. Otte, Helga B. Salvesen, Ingeborg Bachmann, Jarle B. Arnes and Johan Eide and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Karin Collett

27 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

2005 694 citations Ingeborg Bachmann, Ole J. Halvorsen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Collett Norway	15	1.1k	640	626	347	205	31	1.9k
Tomás Bonome United States	15	1.2k 1.1×	457 0.7×	643 1.0×	239 0.7×	211 1.0×	23	2.0k
Heini Lassus Finland	25	1.0k 0.9×	830 1.3×	555 0.9×	184 0.5×	179 0.9×	44	2.0k
Hong Sug Kim South Korea	26	1.5k 1.3×	621 1.0×	428 0.7×	349 1.0×	209 1.0×	36	1.9k
Wiam Bshara United States	25	811 0.7×	746 1.2×	402 0.6×	314 0.9×	328 1.6×	73	1.7k
Nikita Makretsov Canada	14	682 0.6×	593 0.9×	380 0.6×	164 0.5×	164 0.8×	19	1.4k
Xavier Sanjuán Spain	20	839 0.7×	667 1.0×	359 0.6×	278 0.8×	250 1.2×	55	1.7k
Yajun Yi United States	22	969 0.8×	389 0.6×	490 0.8×	247 0.7×	320 1.6×	31	1.7k
Jaana Lahti‐Domenici United States	13	1.3k 1.1×	1.1k 1.8×	750 1.2×	269 0.8×	252 1.2×	13	2.3k
Min Hye Jang South Korea	20	610 0.5×	1.0k 1.6×	473 0.8×	303 0.9×	279 1.4×	42	1.7k
Peter Horak Germany	20	1.2k 1.1×	457 0.7×	590 0.9×	235 0.7×	242 1.2×	68	1.9k

Countries citing papers authored by Karin Collett

Since Specialization

Citations

This map shows the geographic impact of Karin Collett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Collett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Collett more than expected).

Fields of papers citing papers by Karin Collett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Collett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Collett. The network helps show where Karin Collett may publish in the future.

Co-authorship network of co-authors of Karin Collett

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Collett. A scholar is included among the top collaborators of Karin Collett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Collett. Karin Collett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aas, Turid, Ingeborg Winge, Karin Collett, et al.. (2025). Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer. The Journal of Pathology Clinical Research. 11(6). e70050–e70050.

Kessler, Jörg, et al.. (2024). Placental pathology and neonatal morbidity: exploring the impact of gestational age at birth. BMC Pregnancy and Childbirth. 24(1). 201–201.

Ebbing, Cathrine, Jörg Kessler, Olav H. Haugen, et al.. (2021). Placental histology predicted adverse outcomes in extremely premature neonates in Norway—population‐based study. Acta Paediatrica. 111(3). 546–553. 9 indexed citations

Wik, Elisabeth, Kenneth Finne, Even Birkeland, et al.. (2020). Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups. Scientific Reports. 10(1). 2914–2914. 17 indexed citations

Gierman, Lobke, Bjørnar Sporsheim, Mattijs Elschot, et al.. (2020). Cholesterol Crystals and NLRP3 Mediated Inflammation in the Uterine Wall Decidua in Normal and Preeclamptic Pregnancies. Frontiers in Immunology. 11. 564712–564712. 19 indexed citations

Tangerås, Line Haugstad, Lobke Gierman, Karin Collett, et al.. (2018). Placental inflammation by HMGB1 activation of TLR4 at the syncytium. Placenta. 72-73. 53–61. 25 indexed citations

Lindemann, Paul Christoffer, et al.. (2018). Fetal cerebral malakoplakia associated with recurrent facial erysipelas of the mother. Clinical Neuropathology. 38(3). 80–83.

Klingen, Tor Audun, Ying Chen, Ingunn M. Stefansson, et al.. (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. Journal of Clinical Pathology. 70(4). 313–319. 16 indexed citations

Stefansson, Ingunn M., et al.. (2014). Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays. PLoS ONE. 9(11). e112121–e112121. 52 indexed citations

10.

Krüger, Kristi, Ingunn M. Stefansson, Karin Collett, et al.. (2012). Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. The Breast. 22(3). 282–288. 51 indexed citations

11.

Krüger, Kristi, Ingunn M. Stefansson, Karin Collett, et al.. (2012). Abstract 1372: Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. Cancer Research. 72(8_Supplement). 1372–1372. 1 indexed citations

12.

Mæhle, Bjørn O., Karin Collett, Steinar Tretli, Lars A. Akslen, & Tom Grotmol. (2009). Estrogen receptor β– an independent prognostic marker in estrogen receptor α and progesterone receptor‐positive breast cancer?. Apmis. 117(9). 644–650. 20 indexed citations

13.

Arnes, Jarle B., Karin Collett, & Lars A. Akslen. (2008). Independent prognostic value of the basal‐like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI‐1. Histopathology. 52(3). 370–380. 34 indexed citations

14.

Collett, Karin, Geir Egil Eide, Jarle B. Arnes, et al.. (2006). Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.. Clinical Cancer Research. 12(4). 1168–1174. 226 indexed citations

15.

Collett, Karin, Ingunn M. Stefansson, Johan Eide, et al.. (2005). A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors. Cancer Epidemiology Biomarkers & Prevention. 14(5). 1108–1112. 170 indexed citations

16.

Bachmann, Ingeborg, Ole J. Halvorsen, Karin Collett, et al.. (2005). EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast. Journal of Clinical Oncology. 24(2). 268–273. 694 indexed citations breakdown →

17.

Collett, Karin, Rolv Skjærven, & Bjørn O. Mæhle. (1998). The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index. Breast Cancer Research and Treatment. 48(1). 1–9. 16 indexed citations

18.

Collett, Karin, Bjørn O. Mæhle, Rolv Skjærven, & Turid Aas. (1996). Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer. The Breast. 5(3). 123–126. 9 indexed citations

19.

Collett, Karin, Rolv Skjærven, Thor Thorsen, F Hartveit, & Bjørn O. Mæhle. (1989). The prognostic role of progesterone receptor status and age in relation to axillary node status in breast cancer patients. European Journal of Cancer and Clinical Oncology. 25(6). 959–964. 4 indexed citations

20.

Collett, Karin, et al.. (1980). Purpuric rash due to epsilon-aminocaproic acid.. BMJ. 281(6234). 197.2–198. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact